Home/Pipeline/Uprifosbuvir (K-579)

Uprifosbuvir (K-579)

Erectile Dysfunction

ApprovedMarketed

Key Facts

Indication
Erectile Dysfunction
Phase
Approved
Status
Marketed
Company

About Kissei Pharmaceutical

Kissei Pharmaceutical is a mid-sized, research-driven Japanese pharmaceutical company with a history spanning over 70 years. Its strategic focus lies in developing and marketing novel drugs for urological, nephrological, and metabolic disorders, while also engaging in licensing and collaborative partnerships to expand its portfolio. The company leverages its expertise in drug discovery and development to address unmet medical needs, with a commercial presence in Japan and through international partnerships. Its financial stability is supported by marketed products and a pipeline of clinical-stage candidates.

View full company profile

Other Erectile Dysfunction Drugs

DrugCompanyPhase
ViagraViatrisApproved
ManforceMankind PharmaCommercial
Mango EDMangoceuticalsApproved/Commercial
STENDRA (avanafil)Petros PharmaceuticalsApproved (Rx); Seeking OTC Switch